Agendia signs a service agreement with Eugene for France distribution.

Agendia, a precision oncology company that develops and markets genomic diagnostic products which help support physicians with their complex treatment decisions, has signed a service agreement with Eugene, a French-based company with a scope of business mainly focused

on bringing solutions to hospitals, clinics, laboratories and physicians, for the promotion,

marketing and distribution of MammaPrint and BluePrint in France.